所有图片(1)

文件

Y0000762

巴比妥酸

Name: 巴比妥酸
Brand: SIAL

European Pharmacopoeia (EP) Reference Standard

别名:

2,4,6-三羟基嘧啶, 丙二酰脲

登录查看公司和协议定价

所有图片(1)

About This Item

经验公式（希尔记法）:

C₄H₄N₂O₃

CAS号:

67-52-7

分子量:

128.09

Beilstein:

120502

MDL编号:

MFCD00006666

UNSPSC代码:

41116107

PubChem化学物质编号:

329831134

NACRES:

NA.24

等级

pharmaceutical primary standard

API类

fluorouracil

制造商/商品名称

EDQM

mp

248-252 °C (dec.) (lit.)

应用

pharmaceutical (small molecule)

格式

neat

储存温度

2-8°C

SMILES字符串

O=C1CC(=O)NC(=O)N1

InChI

1S/C4H4N2O3/c7-2-1-3(8)6-4(9)5-2/h1H2,(H2,5,6,7,8,9)

InChI key

HNYOPLTXPVRDBG-UHFFFAOYSA-N

正在寻找类似产品? 访问产品对比指南

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

应用

Fluorouracil impurity A EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

包装

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

其他说明

Sales restrictions may apply.

WGK

WGK 1

闪点(°F)

closed cup

闪点(°C)

closed cup

Choose from one of the most recent versions:

分析证书(COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact 客户支持

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Identifying barbiturate binding sites in a nicotinic acetylcholine receptor with [3H]allyl m-trifluoromethyldiazirine mephobarbital, a photoreactive barbiturate.

Ayman K Hamouda et al.

Molecular pharmacology, 85(5), 735-746 (2014-02-25)

At concentrations that produce anesthesia, many barbituric acid derivatives act as positive allosteric modulators of inhibitory GABAA receptors (GABAARs) and inhibitors of excitatory nicotinic acetylcholine receptors (nAChRs). Recent research on [(3)H]R-mTFD-MPAB ([(3)H]R-5-allyl-1-methyl-5-(m-trifluoromethyldiazirinylphenyl)barbituric acid), a photoreactive barbiturate that is a potent

Hydrolytic pathway of 5-fluorouracil in aqueous solutions for clinical use.

Rémi Legay et al.

Journal of pharmaceutical and biomedical analysis, 98, 446-462 (2014-07-20)

The purpose of the study was to investigate the degradation pathway of 5-fluorouracil (FU) in the situation of commercial formulations for clinical use, namely FU dissolved in sodium hydroxide (NaOH) solutions or Tris buffer at pH 8.5-9. Combination of data

Is there new hope for therapeutic matrix metalloproteinase inhibition?

Roosmarijn E Vandenbroucke et al.

Nature reviews. Drug discovery, 13(12), 904-927 (2014-11-08)

Matrix metalloproteinases (MMPs) are zinc-dependent endopeptidases that form a family of 24 members in mammals. Evidence of the pathological roles of MMPs in various diseases, combined with their druggability, has made them attractive therapeutic targets. Initial drug discovery efforts focused

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门

文件